Bristol-Myers Squibb (BMY) Short Interest Ratio & Short Volume → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free BMY Stock Alerts $44.11 -0.44 (-0.99%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Bristol-Myers Squibb Short Interest DataCurrent Short Volume28,020,000 sharesPrevious Short Volume34,360,000 sharesChange Vs. Previous Month-18.45%Dollar Volume Sold Short$1.23 billionShort Interest Ratio / Days to Cover1.8Last Record DateApril 30, 2024Outstanding Shares2,027,100,000 sharesFloat Size2,030,000,000 sharesShort Percent of Float1.38%Today's Trading Volume15,765,096 sharesAverage Trading Volume15,553,328 sharesToday's Volume Vs. Average101% Short Selling Bristol-Myers Squibb ? Sign up to receive the latest short interest report for Bristol-Myers Squibb and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBMY Short Interest Over TimeBMY Days to Cover Over TimeBMY Percentage of Float Shorted Over Time Ad The Oxford Club348 million Americans lives to END as we know it?348 million American lives are about to change FOREVER.... Because thanks to one shocking A.I. development I'm revealing for the first time today...To see my free research, simply click here now. Bristol-Myers Squibb Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202428,020,000 shares $1.23 billion -18.5%1.4%1.8 $43.96 4/15/202434,360,000 shares $1.67 billion -2.2%1.7%2.2 $48.51 3/31/202435,120,000 shares $1.90 billion -5.7%1.7%2.2 $54.23 3/15/202437,250,000 shares $1.96 billion +14.1%1.8%2.2 $52.49 2/29/202432,650,000 shares $1.66 billion +3.7%1.6%2.1 $50.73 2/15/202431,490,000 shares $1.56 billion +1.3%1.6%2.1 $49.45 Get the Latest News and Ratings for BMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bristol-Myers Squibb and its competitors with MarketBeat's FREE daily newsletter. 1/31/202431,090,000 shares $1.52 billion +6.5%1.5%2 $48.87 1/15/202429,190,000 shares $1.47 billion +30.8%1.4%1.9 $50.31 12/31/202322,310,000 shares $1.14 billion -7.4%1.1%1.5 $51.31 12/15/202324,100,000 shares $1.23 billion -11.3%1.2%1.7 $50.84 11/30/202327,170,000 shares $1.34 billion +1.4%1.3%2 $49.38 11/15/202326,800,000 shares $1.38 billion +14.5%1.3%2.1 $51.60 10/31/202323,400,000 shares $1.21 billion -12.5%1.2%1.9 $51.53 10/15/202326,750,000 shares $1.51 billion -15.3%1.3%2.4 $56.47 9/30/202331,590,000 shares $1.83 billion -14.6%1.5%2.9 $58.04 9/15/202336,980,000 shares $2.18 billion -15.5%1.8%3.5 $59.00 8/31/202343,760,000 shares $2.70 billion -18.2%2.1%4.4 $61.65 8/15/202353,510,000 shares $3.30 billion +221.6%2.6%5.6 $61.75 7/31/202316,640,000 shares $1.04 billion -8.6%0.8%1.9 $62.20 7/15/202318,210,000 shares $1.13 billion +1.2%0.9%2.2 $61.94 6/30/202318,000,000 shares $1.15 billion -1.9%0.9%2.2 $63.94 6/15/202318,340,000 shares $1.19 billion -2.7%0.9%2.3 $64.68 5/31/202318,840,000 shares $1.21 billion -12.3%0.9%2.3 $64.44 5/15/202321,490,000 shares $1.46 billion +13.6%1.0%2.7 $68.17 4/30/202318,920,000 shares $1.26 billion +5.8%0.9%2.4 $66.77 4/15/202317,880,000 shares $1.26 billion +3.5%0.9%2.3 $70.45 3/31/202317,270,000 shares $1.20 billion -17.0%0.8%2.1 $69.31 3/15/202320,810,000 shares $1.40 billion +22.3%1.0%2.5 $67.48 2/28/202317,020,000 shares $1.17 billion -4.0%0.8%2.1 $68.96 2/15/202317,720,000 shares $1.27 billion -14.5%0.9%2.1 $71.47 1/31/202320,720,000 shares $1.51 billion -1.2%1.0%2.3 $72.65 1/15/202320,960,000 shares $1.52 billion +14.9%1.0%2.3 $72.51 12/30/202218,250,000 shares $1.31 billion -26.7%0.9%2 $71.95 12/15/202224,880,000 shares $1.87 billion -1.4%1.2%2.6 $75.00 11/30/202225,220,000 shares $2.02 billion +3.5%1.2%2.6 $80.28 11/15/202224,360,000 shares $1.86 billion -1.7%1.2%2.5 $76.28 10/31/202224,770,000 shares $1.92 billion +7.3%1.2%2.6 $77.47 10/15/202223,080,000 shares $1.63 billion -4.6%1.1%2.5 $70.62 9/30/202224,180,000 shares $1.72 billion +4.7%1.1%2.5 $71.09 9/15/202223,090,000 shares $1.66 billion +1.7%1.1%2.4 $71.78[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. BMY Short Interest - Frequently Asked Questions What is Bristol-Myers Squibb's current short interest? Short interest is the volume of Bristol-Myers Squibb shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 28,020,000 shares of BMY short. 1.38% of Bristol-Myers Squibb's shares are currently sold short. Learn More on Bristol-Myers Squibb's current short interest. What is a good short interest ratio for Bristol-Myers Squibb? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BMY shares currently have a short interest ratio of 2.0. Learn More on Bristol-Myers Squibb's short interest ratio. Which institutional investors are shorting Bristol-Myers Squibb? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Bristol-Myers Squibb: Jane Street Group LLC, CMT Capital Markets Trading GmbH, BlueCrest Capital Management Ltd, Paloma Partners Management Co, PEAK6 Investments LLC, National Bank of Canada FI, JPMorgan Chase & Co., XR Securities LLC, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., SpiderRock Advisors LLC, Caas Capital Management LP, Simplex Trading LLC, IMC Chicago LLC, Nomura Holdings Inc., and Readystate Asset Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Bristol-Myers Squibb? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.38% of Bristol-Myers Squibb's floating shares are currently sold short. Is Bristol-Myers Squibb's short interest increasing or decreasing? Bristol-Myers Squibb saw a drop in short interest in April. As of April 30th, there was short interest totaling 28,020,000 shares, a drop of 18.5% from the previous total of 34,360,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Bristol-Myers Squibb's float size? Bristol-Myers Squibb currently has issued a total of 2,027,100,000 shares. Some of Bristol-Myers Squibb's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bristol-Myers Squibb currently has a public float of 2,030,000,000 shares. How does Bristol-Myers Squibb's short interest compare to its competitors? 1.38% of Bristol-Myers Squibb's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Bristol-Myers Squibb: Zoetis Inc. (1.13%), Pfizer Inc. (1.10%), AbbVie Inc. (0.82%), Merck & Co., Inc. (0.74%), GSK plc (0.44%), Regeneron Pharmaceuticals, Inc. (1.42%), Vertex Pharmaceuticals Incorporated (1.50%), Sanofi (0.22%), Takeda Pharmaceutical Company Limited (0.20%), Abbott Laboratories (0.84%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Bristol-Myers Squibb stock? Short selling BMY is an investing strategy that aims to generate trading profit from Bristol-Myers Squibb as its price is falling. BMY shares are trading down $0.44 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bristol-Myers Squibb? A short squeeze for Bristol-Myers Squibb occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BMY, which in turn drives the price of the stock up even further. How often is Bristol-Myers Squibb's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BMY, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ZTS Short Interest PFE Short Interest ABBV Short Interest MRK Short Interest GSK Short Interest REGN Short Interest VRTX Short Interest SNY Short Interest TAK Short Interest ABT Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:BMY) was last updated on 5/17/2024 by MarketBeat.com Staff From Our Partners348 million Americans lives to END as we know it?The Oxford ClubCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceGold Set to EXPLODE!Gold Safe ExchangeInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable Prosperity